# The right medication, the right indication? Evaluating antipsychotic prescribing in adults with learning disabilities in primary care: a clinical audit - URL: https://alisanburak.com/en/wcp-2026-posterler/ev0682 - Language: en - Last updated: not specified - Page title: The right medication, the right indication? Evaluating antipsychotic prescribing in adults with learning disabilities in primary care: a clinical audit | WCP 2026 Summary > A clinical indication was documented for all antipsychotic prescriptions, but specialist follow-up and deprescribing planning fell short of the standards. This page was translated automatically from Turkish. [Read the original](https://alisanburak.com/wcp-2026-posterler/ev0682) This page is an AI-assisted Turkish summary of the study presented at the 26th World Congress of Psychiatry. The study belongs to the presenting authors; please refer to the original source when citing it. EV0682 E-PosterPsychopharmacologyRetrospective clinical audit # The right medication, the right indication? Evaluating antipsychotic prescribing in adults with learning disabilities in primary care: a clinical audit RIGHT DRUG, RIGHT INDICATION? EVALUATING ANTIPSYCHOTIC (AP) PRESCRIBING IN ADULTS WITH LEARNING DISABILITY (LD) IN PRIMARY CARE – A CLINICAL AUDIT Presenter: Subhan S. Khan Country: United Kingdom Institution: University of Southampton, Faculty of Medicine A clinical indication was documented for all antipsychotic prescriptions, but specialist follow-up and deprescribing planning fell short of the standards. The study aimed to assess the appropriateness and safety of antipsychotic prescribing in adults with learning disabilities against NICE NG11, NICE QS101 and STOMP quality standards. A retrospective clinical audit was conducted at a single primary care practice using the EMISweb patient database; data were collected on documented clinical indications, specialist review within the previous 12 months, annual physical health monitoring and medication review plans. Of the 15,336 registered patients, 42 (0.27%) were on the learning disability register, and 10 of these (24%) had an active antipsychotic prescription; the analysis therefore included these 10 patients. A clinical indication was documented in 100% (10/10), specialist review within 12 months in 70% (7/10), annual physical health monitoring in 80% (8/10), and a dose reduction or discontinuation plan in 70% (7/10). The graph in the poster showed NICE/STOMP compliance targets of 90%, 90%, 80% and 90%, respectively, for these four standards. Referral delays and gaps in documentation were the main reasons for failure to meet the monitoring standards. The authors noted that, although documentation of indications was strong, shortcomings in specialist follow-up and deprescribing highlighted the challenges of implementing STOMP principles in primary care and the need to strengthen longitudinal monitoring systems. A repeat audit and the introduction of STOMP-aligned EMIS monitoring templates were planned as the next steps. [View the original poster](https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/436) How to cite this study APA 7: Khan, S. S. (2026, September 23-26). Right drug, right indication? evaluating antipsychotic (ap) prescribing in adults with learning disability (ld) in primary care – a clinical audit [E-poster]. 26th WPA World Congress of Psychiatry (WCP 2026), Stockholm, Sweden. https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/436 Vancouver: Khan SS. Right drug, right indication? evaluating antipsychotic (ap) prescribing in adults with learning disability (ld) in primary care – a clinical audit [e-poster]. 26th WPA World Congress of Psychiatry (WCP 2026); 2026 Sep 23-26; Stockholm, Sweden. Available from: https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/436 Author names and title formatting were generated automatically from the congress system; please check them against the original poster before use. ## On the same topic - [Açığı kapatmak: erişkin DEHB ilacı başlanmadan önce EKG sevk uyumunun iyileştirilmesi, kapalı döngü klinik denetim](https://alisanburak.com/en/wcp-2026-posterler/ev0088) - [Anksiyete bozukluğu olan hastalarda psikobiyotik müdahalesi: ısıl işlem görmüş Lactobacillus paracasei PS23'ün etkilerini inceleyen çift kör randomize kontrollü çalışma](https://alisanburak.com/en/wcp-2026-posterler/ev0126) - [Otizm spektrum bozukluğunda bumetanidin tedavi edici potansiyeli: güncel kanıtlar ve gelecek yönelimleri](https://alisanburak.com/en/wcp-2026-posterler/ev0157) - [Verbaskozid ile otizm spektrum bozukluğu tedavisinin mekanizmaları: ağ farmakolojisi, moleküler yerleştirme ve moleküler dinamik temelli inceleme](https://alisanburak.com/en/wcp-2026-posterler/ev0172) - [Otizm spektrum bozukluğunun çekirdek belirtilerinin tedavisinde kannabidiol: sistematik derleme](https://alisanburak.com/en/wcp-2026-posterler/ev0186) [All WCP 2026 summaries](https://alisanburak.com/en/wcp-2026-posterler) --- Kaynak / Source: https://alisanburak.com/en/wcp-2026-posterler/ev0682 İletişim / Contact: Bağdat Caddesi, Veli Güneysu Apt. No:453 K:4 D:9, Suadiye / Kadıköy, İstanbul · +90 532 642 95 25 · info@alisanburak.com · https://alisanburak.com/bagdat-caddesi-psikoterapi-iletisim